N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide
C24H28ClFN2O2S — CID 170345326
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide
N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide (PubChem CID 170345326) has the molecular formula C24H28ClFN2O2S and a molecular weight of 463.02 g/mol. Its IUPAC name is N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide.
Molecular Properties
| Compound Name | N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide |
|---|---|
| PubChem CID | 170345326 |
| Molecular Formula | C24H28ClFN2O2S |
| Molecular Weight | 463.02 g/mol |
| Exact Mass | 462.15 |
| IUPAC Name | N-[(1R)-1-[6-(2-chloro-6-fluorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide |
| SMILES | C[C@@H](NS(=O)(=O)C1CC1)c1cn(CC(C)(C)C)c2cc(-c3c(F)cccc3Cl)ccc12 |
| InChI | InChI=1S/C24H28ClFN2O2S/c1-15(27-31(29,30)17-9-10-17)19-13-28(14-24(2,3)4)22-12-16(8-11-18(19)22)23-20(25)6-5-7-21(23)26/h5-8,11-13,15,17,27H,9-10,14H2,1-4H3/t15-/m1/s1 |
| InChIKey | UTKFRDHGYQMUNO-OAHLLOKOSA-N |
| XLogP | 6.29 |
| TPSA | 51.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.02 |
| LogP ≤ 5 | 6.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170345326 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.